Healthcare
Live Price
Offline$0.41
-6.82% today
1Y Change
-66.51%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zentek Ltd. (ZTEK) is a Healthcare stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $0.41 and down 66.5% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +2826.3%, EPS growth of +16.7%, a dividend yield of 0.0%. What stands out right now is revenue +2826.3%, EPS +16.7%, free cash flow -1.7% with operating margin -928.4% and ROIC -61.5%. Valuation already assumes a fairly strong business story at price/sales 77.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ZTEK price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZTEK
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZTEK Max Drawdown
-68.42%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ZTEK and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.4K
-99.3% YoY
FY Net Income
-$3.9M
+87.8% YoY
Free Cash Flow
-$2.0M
+82.9% YoY
Revenue Growth
+2826.3%
EPS Growth
+16.7%
Gross Margin
-74.8%
Net Margin
-857.1%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 872K | 30K | 73K | 340K | 2K |
| Gross Profit | 192K | -301K | -780K | -37K | -194K |
| Operating Income | -10M | -12M | -15M | -13M | -4M |
| EBITDA | -9M | -11M | -14M | -31M | -4M |
| Net Income | -10M | -12M | -14M | -32M | -4M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 121K | 385K | 10M | 21M | 3M |
| Total Assets | 18M | 17M | 33M | 36M | 30M |
| Total Liabilities | 4M | 2M | 3M | 3M | 3M |
| Shareholder Equity | 15M | 15M | 30M | 33M | 27M |
| Total Debt | 680K | 917K | 2M | 2M | 404K |
| Net Debt | 559K | 532K | -9M | -19M | -3M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2M
+77.5% YoY
Capital Expenditures
254K
+93.6% YoY
Free Cash Flow
2M
+82.9% YoY
Key ratios
Gross Margin
-74.8%
Operating Margin
-928.4%
Net Margin
-857.1%
ROE
-61.3%
Debt / Equity
0.15x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.